These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18030606)

  • 21. Formulation-dependent pharmacokinetics and pharmacodynamics of propofol in rats.
    Dutta S; Ebling WF
    J Pharm Pharmacol; 1998 Jan; 50(1):37-42. PubMed ID: 9504432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicochemical Characterization and Pharmacological Evaluation of Novel Propofol Micelles with Low-Lipid and Low-Free Propofol.
    Chu Y; Sun T; Xie Z; Sun K; Jiang C
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and evaluation of an alternative triglyceride-free propofol microemulsion.
    Cho J; Cho JC; Lee P; Lee M; Oh E
    Arch Pharm Res; 2010 Sep; 33(9):1375-87. PubMed ID: 20945136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo evaluation of a simple microemulsion formulation for propofol.
    Li G; Fan Y; Li X; Wang X; Li Y; Liu Y; Li M
    Int J Pharm; 2012 Apr; 425(1-2):53-61. PubMed ID: 22266535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamic evaluation and physical/chemical analysis of two formulations of propofol used in target-controlled infusion.
    Simoni RF; de Paula Gomes Miziara LE; Esteves LO; Ribeiro D'Castro JG; Morales CA; Esqueapatti Sandrin CE; Contente TC; Oliveira-Silva D
    Braz J Anesthesiol; 2013; 63(1):59-65. PubMed ID: 23438801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanostructured Lipid Carrier of Propofol: a Promising Alternative to Marketed Soybean Oil-Based Nanoemulsion.
    Shevalkar G; Pai R; Vavia P
    AAPS PharmSciTech; 2019 May; 20(5):201. PubMed ID: 31139968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of bacterial growth by lignocaine in propofol emulsion.
    Ozer Z; Ozturk C; Altunkan AA; Cinel I; Oral U
    Anaesth Intensive Care; 2002 Apr; 30(2):179-82. PubMed ID: 12002925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of hydroponically alginate nanoparticles as novel carrier for intravenous delivery of propofol.
    Hassani Najafabadi A; Azodi-Deilami S; Abdouss M; Payravand H; Farzaneh S
    J Mater Sci Mater Med; 2015 Mar; 26(3):145. PubMed ID: 25743747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans.
    Wasan EK; Bartlett K; Gershkovich P; Sivak O; Banno B; Wong Z; Gagnon J; Gates B; Leon CG; Wasan KM
    Int J Pharm; 2009 May; 372(1-2):76-84. PubMed ID: 19236839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New drug, fospropofol disodium: a propofol prodrug.
    Welliver M; Rugari SM
    AANA J; 2009 Aug; 77(4):301-8. PubMed ID: 19731849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth curves of Staphylococcus aureus, Candida albicans, and Moraxella osloensis in propofol and other media.
    Tessler M; Dascal A; Gioseffini S; Miller M; Mendelson J
    Can J Anaesth; 1992 May; 39(5 Pt 1):509-11. PubMed ID: 1534525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of propofol microemulsion and lipid emulsion after an intravenous bolus and variable rate infusion.
    Kim KM; Choi BM; Park SW; Lee SH; Christensen LV; Zhou J; Yoo BH; Shin HW; Bae KS; Kern SE; Kang SH; Noh GJ
    Anesthesiology; 2007 May; 106(5):924-34. PubMed ID: 17457123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacodynamics of two different propofol formulations].
    Ihmsen H; Jeleazcov C; Schüttler J; Schwilden H; Bremer F
    Anaesthesist; 2006 Jun; 55(6):635-42. PubMed ID: 16479409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of lidocaine on the globule size distribution of propofol emulsions.
    Park JW; Park ES; Chi SC; Kil HY; Lee KH
    Anesth Analg; 2003 Sep; 97(3):769-771. PubMed ID: 12933399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleep deprivation potentiates the onset and duration of loss of righting reflex induced by propofol and isoflurane.
    Tung A; Szafran MJ; Bluhm B; Mendelson WB
    Anesthesiology; 2002 Oct; 97(4):906-11. PubMed ID: 12357158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acidified propofol retains its anaesthetic potency after storage.
    Eriksson M; Englesson S; Hartvig P
    Eur J Anaesthesiol; 1999 Mar; 16(3):166-8. PubMed ID: 10225165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial activity of remifentanil and mixtures of remifentanil and propofol.
    Apan TZ; Apan A; Sahin S; Cakirca M
    J Clin Anesth; 2007 Aug; 19(5):346-50. PubMed ID: 17869984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inclusion complexation of propofol with 2-hydroxypropyl-beta-cyclodextrin. Physicochemical, nuclear magnetic resonance spectroscopic studies, and anesthetic properties in rat. trapani@ippo.uniba.it.
    Trapani G; Latrofa A; Franco M; Lopedota A; Sanna E; Liso G
    J Pharm Sci; 1998 Apr; 87(4):514-8. PubMed ID: 9548907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy comparison of the novel water-soluble propofol prodrug HX0969w and fospropofol in mice and rats.
    Zhou Y; Yang J; Liu J; Wang Y; Zhang WS
    Br J Anaesth; 2013 Nov; 111(5):825-32. PubMed ID: 23801745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propofol: an immunomodulating agent.
    Marik PE
    Pharmacotherapy; 2005 May; 25(5 Pt 2):28S-33S. PubMed ID: 15899746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.